Ads
related to: largest generic drug companies
Search results
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 5 days agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Raskin presses insurers, PBMs on free contraception coverage
The Hill via Yahoo News· 5 days agoThe top Democrat on the House Oversight and Accountability Committee wants to know how the country’s...
U.S. House Committee on Oversight and Accountability Democrats Ranking Member Raskin Urges Insurers...
Sierra Sun Times· 3 days agoWashington, D.C. - On Thursday, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, sent letters to the five of the largest health insurers and four of the largest ...
Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
Digital Journal· 5 days agoLaxxon's pipeline includes ongoing working-projects with...research universities, in addition to 13 in-house Advanced Patented Generics products. Laxxon's IP is continuously ...
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Morningstar· 6 days agoThe Company has also received notice of a new Paragraph IV certification...Norwich advising that it has submitted to the U.S. Food and Drug Administration ...
Indiana hospital prices 8th-highest in nation, study finds, but hospitals dismiss analysis
Indiana Capital Chronicle via Yahoo News· 7 days agoU.S. Sen. Mike Braun — the Republican nominee for Indiana governor — made a surprise appearance at...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoActive Pharmaceutical Ingredient Market Worth $238.3 billion | MarketsandMarkets™ PR Newswire CHICAGO, May 17, 2024 CHICAGO, May 17, 2024 /PRNewswire/ -- Active Pharmaceutical Ingredient Market in terms of revenue was estimated to be worth $163.
Large and Unjustified: Second Circuit Clarifies Pleading Requirements in Reverse Payments Cases | JD...
JD Supra· 5 days agoCourt case on reverse payment settlements—the Second Circuit for the first time weighed in on whether (and how) antitrust plaintiffs’ identification of a so-called "side deal" between a patent ...
Narendra Modi’s flagship growth scheme is off to a sluggish start
The Economist· 5 days agoIn the early 1990s India abandoned the principles of swadeshi, or self-sufficiency, that had guided...
Fewer US overdose deaths were reported last year, but experts are still cautious
Associated Press· 6 days agoThe number of U.S. fatal overdoses fell last year, according to Centers for Disease Control and...
